Faster stroke treatment.
Improve outcomes.

When it comes to acute stroke, everyone deserves the best care. Today, more patients can benefit from mechanical thrombectomy through changed guidelines, which widen the time window for endovascular treatment.¹

Faster stroke treatment.
Improve outcomes.

Access the full video³ of Raul Nogueira at LINNC 2019 here.

Why Direct to Angio Suite?

At Philips, our goal is to help stroke centers shorten door to re-perfusion times for ischemic stroke by optimizing workflow and protocols, inspired by established STEMI re-perfusion treatment.²

To achieve this, we are working with leading stroke centers on the development of innovative solutions aimed at further improving image quality, while enhancing workflows to shorten re-perfusion treatment times after ischemic stroke.

Combined, these factors offer great potential for stroke centers to treat more people, faster, improving clinical outcomes.

That’s health with no bounds.

The Direct to Angio Suite workflow at a glance

Direct to Angio Suite – a one-stop stroke shop

The Direct to Angio Suite workflow provides valuable, time-saving support for transfer and direct patients who arrive at the comprehensive stroke center (CSC).

Time to reperfusion is fundamental in reducing morbidity and mortality in acute stroke.^4,5In patients presenting directly to an endovascular-capable center, emphasis has now been placed on fast door-to-imaging times and fast imaging to groin access times. Patients who initially present to an external facility face additional sources of delay with prolonged door in-door out times, transport times, and additional testing at the endovascular-capable center hospital.⁶

Direct to Angio Suite workflows allow for comprehensive stroke diagnosis to be performed directly in the neuro angio suite. This provides valuable, time-saving support for critical patients in acute need of mechanical thrombectomy therapy.

"Significant advances in technology mean that we are now able to identify, plan and treat ischemic stroke patients in the angiography suite, without the need for a separate CT or MR scan."

Watch Raul G. Nogueira's presentation at LINNC 2019.

Access full video

The next paradigm shift in stroke treatment.

Contact information

* This field is mandatory

Country

Contact details

First name*

Last name*

Salutation

Academic title

Email address*

Phone

Company details

Company

Job title*

Specialty

State or Province

Zip or Postal Code

What is cross border data transfer?

I agree on cross-border transfer of personal information.

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behaviour.

Contact information

* This field is mandatory

Country

Contact details

First name*

Last name*

Salutation

Academic title

Email address*

Phone

Company details

Company

Job title*

Specialty

State or Province

Zip or Postal Code

What is cross border data transfer?

I agree on cross-border transfer of personal information.

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behaviour.

Contact information

* This field is mandatory

Country

First name*

First name (phonetic)

Last name*

Last name (phonetic)

Salutation

Academic title

Email address*

Business phone

Company*

Job title

Industry

Function

Specialty

Department

State or Province

City

Address

Zip or Postal Code

By specifying your reason for contact we will be able to provide you with a better service.

Follow up information

Preferred method of contact

Best time to call

Estimated time of purchase

Comments

What is cross border data transfer?

I agree on cross-border transfer of personal information.

* Zgoda na kontakt. Wyrażam zgodę na przetwarzanie moich danych osobowych w celu kontaktu ze mną przez firmę Philips lub współpracującego z nią dystrybutora produktów i urządzeń marki Philips w związku z realizacją moich Oczekiwań, które wskazałam/em w niniejszym formularzu.
Co to oznacza?

* Zgoda na przekazanie danych dystrybutorowi. Wyrażam zgodę na udostępnienie moich danych osobowych przez firmę Philips współpracującym z nią dystrybutorom produktów i urządzeń marki Philips w celu realizacji moich Oczekiwań, które wskazałem w niniejszym formularzu.
Co to oznacza?

* Wyrażenie obu powyższych zgód jest dobrowolne, ale konieczne, żebyśmy mogli skontaktować się z Tobą i zrealizować Twoje Oczekiwania wyrażone przez Ciebie wniniejszym formularzu.

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behaviour.

Learn more about the neuro suite and stroke treatment

Looking to the future
Looking to the future

Improving the quality of clinical images

Before After

Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.⁷

Before After

Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.⁸

Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.⁹

Improving the quality of clinical images

Before After

Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.⁷

Before After

Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.⁸

Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.⁹

Blog: How tech is transforming the way we treat stroke patients

Atul Gupta, MD, Chief Medical Officer and Interventional Radiologist, Philips Image Guided Therapy, discusses the latest innovations in diagnosing strokes.

Read full blog

Why WE TRUST in Direct to Angio?

Philips has a depth of perspective across image guided therapy and the way we treat stroke patients’ clinical processes, and this expertise can help break the boundaries standing in the way of organizing stroke care around the patient. We are currently conducting clinical studies at a number of leading stroke sites to evaluate new acquisition protocols and assess imaging quality (artefact reduction and image reconstruction) of CBCT (Cone-Beam CT) scans in patients with neurovascular diseases, and assess impact on the workflow compared to the standard of care.¹⁰

In addition to these ongoing studies, Philips will evaluate the potential of these new solutions in the context of a Direct to Angio Suite (DTAS) workflow. A multicenter randomized study ‘Workflow optimization to rEduce Time to endovascular ReperfUsion in Stroke Treatment’ (WE-TRUST) is currently being set up to investigate the potential improvement in clinical outcomes for acute stroke patients with emergent large vessel occlusions. This demonstrates Philips’ on-going commitment to improving acute stroke care.

Learn more about WE-TRUST

Want to learn more about the WE TRUST study?

Contact us

Talk to sales
Advancing acute stroke care
Advancing acute stroke care

Philips Neurosuite in action at NEURI Bicêtre, Paris, France

Advancing acute stroke care

At Philips, we believe that when it comes to acute stroke care, everyone deserves the best care. Our innovative Neuro suite is already delivering advancements in interventional neuroradiology, such as our industry-leading CT-like XperCT, which provides excellent imaging quality to assist interventional neuroradiologists with diagnosis and treatment.

We would like to see even more patients receive the care they need, especially with time being a critical aspect in the treatment of acute strokes.

Explore more

Improving the quality of clinical images

Before After

Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.⁷

Before After

Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.⁸

Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.⁹

Improving the quality of clinical images

Before After

Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.⁷

Before After

Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.⁸

Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.⁹

Pleaceholder: Watch XXXX discussing the value of Direct to Angio Suite at LINCC, or access the full video by clicking the button below."

Prof Laurent Spelle

Brain Vascular Center Beaujon University Hospital, France
Trends shaping the stroke market
Trends shaping the stroke market

Trends shaping the stroke market

Stroke care and treatment is a major challenge for healthcare providers across the globe. In many cases, particularly for patients who have experienced an acute stroke, ‘Time is Brain’ – meaning that the right treatment at the right time could potentially lead to enhanced patient outcomes.

Trends shaping the stroke market

Stroke care and treatment is a major challenge for healthcare providers across the globe. In many cases, particularly for patients who have experienced an acute stroke, ‘Time is Brain’ – meaning that the right treatment at the right time could potentially lead to enhanced patient outcomes.

Stroke is the leading cause of disability, worldwide

~35
million

global stroke prevalence

2nd
leading cause of death

2 in 1000

annual globe incidence

1 in 200
people worldwide are stroke survivors

Improving the quality of clinical images

Before After

Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.⁷

Before After

Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.⁸

Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.⁹

Improving the quality of clinical images

Before After

Philips is evaluating in clinical research the optimization of clinically relevant parameters such as increased acquisition speed, improved contrast resolution and optimized artefact correction.⁷

Before After

Avoiding motion artifacts in restless patients, enabling enhanced depiction of bleedings and avoiding cone-beam artefacts, especially in the posterior fossa are important elements of the ongoing research.⁸

Hemorrhage detection. Comparison between optimized XperCT and Multi Detector CT.⁹

Let's talk

#FutureofIGT

¹ Mokin M, Ansari SA, McTaggart RA, Society of NeuroInterventional Surgery, et al. Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee, Journal of NeuroInterventional Surgery 2019;11:215-220.

²Borja I, Stefan J, Stefan A, et al., ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, Volume 39, Issue 2, 07 January 2018, Pages 119–177, https://doi.org/10.1093/eurheartj/ehx393

³ This presentation contains the first clinical results and experience of using investigational XperCT technology. This XperCT technology is considered work in progress and is not CE marked and not available for sale.

⁴ Mendez B. et al. 2018. Direct Transfer to Angio-Suite to Reduce Workflow Times and Increase Favorable Clinical Outcome. DOI: 10.1161/STROKEAHA.118.021989

⁵ Saver J et al., 2016 Sep 27;316(12):1279-88. doi: 10.1001/jama.2016.13647.

⁶ Jadhav AP, et al. Stroke. 2017;48:1884-1889

⁷ Image courtesy of Dr. Vitor Mendes Pereira; Toronto Western Hospital, Toronto, CAN

⁸ Image courtesy of Dr. Vitor Mendes Pereira; Toronto Western Hospital, Toronto, CAN

⁹ Image courtesy of Dr. Ajay Wakhloo and Dr. Ajit Puri; UMass Medical Center, Worcester, MA, USA. Contains the first clinical results and experience of using investigational XperCT technology. This XperCT technology is considered work in progress and is not CE marked and not available for sale.

¹⁰ The product is a work in progress, is not yet CE-marked and is not available for sale. Not for distribution in the USA.

Faster stroke treatment. Improve outcomes.